YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Novartis India
Novartis India
BSE: 500672NSE: NOVARTINDISIN: INE234A01025

30th-Nov-2021 17:43Source: BSE

Novartis India - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that we are issuing a duplicate share certificate to the shareholder, as per the information received from the Company's Registrar and Share Transfer Agent on November 26, 2021 as detailed in the attachment.

Board Meeting (Novartis India)

Meeting Date

Remark

2022-02-10

Quarterly Results

Sections